Manufacturers Life Insurance Company, The Autolus Therapeutics PLC Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 164,921 shares of AUTL stock, worth $377,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164,921
Previous 164,686
0.14%
Holding current value
$377,669
Previous $573,000
4.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
104Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA24.2MShares$55.5 Million0.02% of portfolio
-
Blackstone Inc New York, NY20.5MShares$46.9 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X018.6MShares$42.5 Million83.42% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$35 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$28.3 Million0.67% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $208M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...